June 3, 2021
has
a
Amsterdam, the Netherlands –
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced positive two-year results from the Tack Optimized Balloon Angioplasty (TOBA) II below-the-knee (BTK) clinical trial. The data show the Philips Tack Endovascular System (4F), a first-of-its kind dissection repair device, provides a sustained treatment effect and positive impact on quality of life for Peripheral Artery Disease (PAD) and Critical Limb Ischemia (CLI) patients at two years. The data was presented by Co-Principal Investigator George Adams, MD, Interventional Cardiologist at Rex Hospital affiliated with the University of North Carolina at Chapel Hill, at the
Renowned Chemist Declines UNC Professorship, Cites Treatment of Hannah-Jones
UNC’s Board of Trustees’ decision to “take no action” on Nikole Hannah-Jones’ tenure application has led a renowned chemist to decline professorship at the university, according to a letter from department faculty.
Over the past two years, UNC’s Department of Chemistry has been working to recruit Professor Lisa Jones – a leading African American chemist renowned for her work in biochemistry, analytical chemistry and biophysics.
Now, according to a letter addressed to UNC Chancellor Kevin Guskiewicz and signed by nearly 40 department faculty, “repercussions from Nikole Hannah-Jones’ tenure case is impacting our ability to recruit and attract a diverse and talented faculty person.”
Samsara, the pioneer of the Connected Operations Cloud, today announced Ann Livermore as the latest addition to the company's board of directors, expanding the total number of directors to eight. She joins existing board members Marc Andreessen, Hemant Taneja, Jonathan Chadwick, Sue Wagner, Sue Bostrom and Samsara co-founders Sanjit Biswas and John Bicket.
Royal Philips
Two-year data from the TOBA II BTK clinical trial demonstrate durability of dissection repair below the knee with the Philips Tack Endovascular System
Two-year data from the TOBA II BTK clinical trial demonstrate durability of dissection repair below the knee with the Philips Tack Endovascular System
June 3, 2021
has
a
Amsterdam, the Netherlands –
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced positive two-year results from the Tack Optimized Balloon Angioplasty (TOBA) II below-the-knee (BTK) clinical trial. The data show the Philips Tack Endovascular System (4F), a first-of-its kind dissection repair device, provides a sustained treatment effect and positive impact on quality of life for Peripheral Artery Disease (PAD) and Critical Limb Ischemia (CLI) patients at two years. The data was presented by Co-Principal Investigator George Adams, MD, Interventional Cardiologist at Rex Hospital affiliated with the Universit
Liberty High School was the first Carroll County Public School to kick off the series of graduations at the Carroll County Agricultural Center and Shipley Arena.